Skip to content

Automated Detection of Metastatic Bone Disease on Bone Scintigraphy Scans

In Silico Clinical Trial Comparing the Reading Accuracy of Doctors and a Deep Learning Algorithm for Detection of Metastatic Bone Disease on Bone Scintigraphy Scans.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05110430
Enrollment
2365
Registered
2021-11-08
Start date
2021-03-10
Completion date
2021-12-31
Last updated
2023-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic Bone Tumor

Brief summary

Bone scintigraphy scans are two dimensional medical images that are used heavily in nuclear medicine. The scans detect changes in bone metabolism with high sensitivity, yet it lacks the specificity to underlying causes. Therefore, further imaging would be required to confirm the underlying cause. The aim of this study is to investigate whether deep learning can improve clinical decision based on bone scintigraphy scans.

Interventions

OTHERDeep learning based detection of metastatic bone disease on bone scintigraphy scans.

The aim is to investigate whether deep learning algorithms can detect bone metastasis with high accuracy and specificity.

Sponsors

Aalborg University Hospital
CollaboratorOTHER
Centre Hospitalier Universitaire de Liege
CollaboratorOTHER
University Hospital, Aachen
CollaboratorOTHER
University of Namur
CollaboratorOTHER
Maastricht University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients who underwent a bone scintigraphy scan that is available with the radiologic report between 2010-2018

Exclusion criteria

* The lack of a bone scan, or corresponding radiologic report

Design outcomes

Primary

MeasureTime frameDescription
The classification performance of DL algorithm compared to the ground truthJune 2021Reporting the performance measures (Area under the curve, accuracy, specificity..etc)

Secondary

MeasureTime frameDescription
Comparing the classification performance of the DL algorithm to that of physiciansJune 2021Correctness of the diagnosis of Dr versus AI (dichotomous variable: correct versus not correct) on a subset of the validation data, using a McNemar statistical test

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026